Vicente Astorga

Farmoquímica del Pacífico (FQP) is Chile's oldest pharmaceutical laboratory, founded in 1834, and one of the five longest-standing in Latin America. With over 190 years of uninterrupted presence in healthcare, FQP develops and commercializes differentiated health solutions across pharmaceuticals, medical devices, and nutritional supplements — covering therapeutic areas including General Medicine, Psychiatry, Traumatology, Pediatrics, and Gynecology. FQP operates across both retail and non-retail channels. In the retail segment, it reaches patients through private pharmacies and e-commerce platforms. In the institutional and non-retail segment, it supplies directly to clinics, hospitals, and CENABAST — Chile's national public procurement agency — positioning FQP as a strategic partner at every level of the healthcare system. Internationally, FQP has expanded into the Peruvian market and is actively building its regional footprint, leveraging deep knowledge of Latin American regulatory frameworks, public procurement dynamics, and market access strategies to support the commercialization of health innovations across the region. For biotech partners, FQP brings a distinctive value proposition: the ability to navigate complex regulatory pathways, translate scientific innovation into market-ready products, and communicate differentiated clinical and commercial value to healthcare professionals, institutions, and patients. This expertise spans the full product lifecycle — from Health Authorties registration and regulatory strategy in Chile and Peru to portfolio positioning, institutional access, and patient engagement. FQP structures its biotech collaboration model around Technology Readiness Levels (TRL), offering sponsorship at early stages (TRL 1–5) and co-investment at advanced development stages (TRL 6–9).